The Food and Drug Administration (FDA) has approved Symbravo ® (meloxicam/rizatriptan) for the acute treatment of migraine with or without aura in adults.
HealthDay News — The US Food and Drug Administration (FDA) has approved the first-ever clinical trials testing pig kidney transplants in people with kidney failure, marking a major step forward in ...
Health care providers are urged to inform patients to periodically check their smartphone settings and to confirm that they are able to receive alerts.
Approval of this indication is based on limited clinical safety and efficacy data for Emblaveo. In REVISIT, study participants with cIAI (n=312) were randomly assigned 2:1 to receive aztreonam ...
Ozempic (semaglutide) Glucagon-like peptide-1 receptor agonist To reduce the risk of sustained estimated glomerular filtration rate decline, end-stage kidney disease, and cardiovascular death in ...
The researchers found that 69,213,936 prescriptions for OMDs were dispensed in the United States during the study period, (HealthDay News) — Prescriptions of obesity management drugs (OMDs) have ...
A higher risk for ischemic heart diseases was associated with IBD only in male patients, whereas a negative association was seen among female patients. HealthDay News — Male patients with ...
Elevated LDL cholesterol, total cholesterol, triglycerides linked to reduced risk for glaucoma. HealthDay News — Elevated high-density lipoprotein cholesterol (HDL-C) is associated with an ...
“Our findings demonstrate that the therapeutic vaccine Vvax001 is safe, well-tolerated, and effective in eradicating HPV16-associated CIN3 lesions and clearing the underlying persistent HPV16 ...
The 2023 match saw a significant number of unfilled programs; of 115 programs, 35 failed to fill all positions. HealthDay News — The number of anesthesiology residents applying to pain medicine ...
ADI-001 is an allogeneic gamma delta CAR T-cell therapy that targets the B-cell antigen CD20. The Food and Drug Administration (FDA) has granted Fast Track designation to ADI-001 for the treatment ...